These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30784665)
21. Parathyroid hormone suppression by cimetidine in the uremic patient. Beehler CJ; Beckner JR; Rosenquist RC; Shankel SW Ann Intern Med; 1980 Dec; 93(6):840-1. PubMed ID: 7447192 [No Abstract] [Full Text] [Related]
22. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis. McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F Nephron; 1977; 19(2):88-94. PubMed ID: 887190 [TBL] [Abstract][Full Text] [Related]
23. Values of intact serum parathyroid hormone in different stages of renal insufficiency. Hellman P; Backman U; Danielson BG; Akerström G; Rastad J; Wide L; Ljunghall S Scand J Urol Nephrol; 1991; 25(3):227-32. PubMed ID: 1947852 [TBL] [Abstract][Full Text] [Related]
24. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis]. Bagon J; Brunfaut C J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994 [No Abstract] [Full Text] [Related]
25. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis]. Kuhlencordt F; Augustin HJ; Kruse HP Dtsch Med Wochenschr; 1970 Oct; 95(42):2122-5. PubMed ID: 4990903 [No Abstract] [Full Text] [Related]
26. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients. Meakins JL; Milne CA; Hollomby DJ; Goltzman D Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120 [TBL] [Abstract][Full Text] [Related]
27. Re-evaluating our approach to calcium and phosphorus management in dialysis patients. Keith DS Am J Kidney Dis; 2001 Jun; 37(6):1331-3. PubMed ID: 11382711 [No Abstract] [Full Text] [Related]
28. Different outcomes following parathyroidectomy in patients with uremic tumoral calcinosis: two case reports. Li J; Li X; Dong X; Ma L; Guo Z; Chen X BMC Nephrol; 2023 Mar; 24(1):55. PubMed ID: 36922797 [TBL] [Abstract][Full Text] [Related]
29. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis]. Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074 [No Abstract] [Full Text] [Related]
30. [Brown tumors in chronic hemodialysis patients]. Gorsane I; Zammouri A; El Meddeb J; Younsi F; Bartkiz A; Abdelmoula J; Barbouch S; Ben Abdallah T Nephrol Ther; 2016 Apr; 12(2):86-93. PubMed ID: 26907666 [TBL] [Abstract][Full Text] [Related]
31. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis. Varghese Z; Moorhead JF; Wills MR Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276 [No Abstract] [Full Text] [Related]
32. Maxillary brown tumor of secondary hyperparathyroidism in a hemodialysis patient. Weiss RR; Schoeneman MJ; Primack W; Rozycki D; Bennett B; Greifer I JAMA; 1980 May; 243(19):1929-30. PubMed ID: 7365977 [No Abstract] [Full Text] [Related]
33. Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature. Pecovnik-Balon B; Kramberger S Am J Nephrol; 1997; 17(1):93-5. PubMed ID: 9057960 [TBL] [Abstract][Full Text] [Related]
34. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits. Hamada J; Tamai K; Ono W; Saotome K J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759 [TBL] [Abstract][Full Text] [Related]